In:
Medicines, MDPI AG, Vol. 9, No. 6 ( 2022-05-24), p. 34-
Abstract:
Cancer development and progression is associated with aberrant changes in cellular glycosylation. Cells expressing altered glycan-structures are recognized by cells of the immune system, favoring the induction of inhibitory immune processes which subsequently promote tumor growth and spreading. Here, we discuss about the importance of glycobiology in modern medicine, taking into account the impact of altered glycan structures expressed in cancer cells as potential glycobiomarkers of disease, as well as on cancer development and progression.
Type of Medium:
Online Resource
ISSN:
2305-6320
DOI:
10.3390/medicines9060034
Language:
English
Publisher:
MDPI AG
Publication Date:
2022
detail.hit.zdb_id:
2777965-8